title: Effectiveness and security of CT-guided percutaneous implantation of (125)I seeds in pancreatic carcinoma.
abstract: OBJECTIVE
  To assess the effectiveness and security of CT-guided percutaneous implantation of iodine-125 ((125)I)-labelled seeds in pancreatic carcinoma.
  
  
  METHODS
  A total of 36 patients (25 males and 11 females) with an average age of 57 years (range, 39-84 years) were enrolled and categorized into Stage III (27 cases) and Stage IV (9 cases) of pancreatic cancer. There were 3 tumours in the pancreatic head and 33 tumours in the pancreatic body or tail. The average diameter of the tumours was 37.1 mm (range, 15-65 mm). The implantation of (125)I seeds was performed by using 18-G needles (length, 150-200 mm) through the anterior, lateral and posterior approaches. Then, (125)I seeds were loaded and released into the lesions.
  
  
  RESULTS
  Implantations were performed via the anterior (23 patients), lateral (9 patients) and posterior (4 patients) approaches. During implantation, 3-14 punctures were performed for each patient, and a total of 164 punctures were recorded. Meanwhile, a total of 657 seeds were implanted with an average of 25.27 (range, 12-50) seeds per patient, and the success rate was 100%. The activity of each seed ranged from 0.55 to 0.65 mCi. A main adverse event occurred in one puncture and minor events in seven punctures. No significant relationship between the punctures or adverse events was identified. No serious complication was detected after the implantations during follow-up visits.
  
  
  CONCLUSIONS
  This study suggested that CT-guided percutaneous implantation of (125)I seeds in a pancreatic carcinoma was relatively safe and effective for treating unresectable pancreatic cancer.
  
  
  CONCLUSIONS
  The CT-guided percutaneous implantation of (125)I seeds in unresectable pancreatic cancer showed highly successful rates without serious complications.
authors.affiliation: 1 Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
authors.forename: Y-P
authors.initials: YP
authors.lastname: Yu
authors.forename: Q
authors.initials: Q
authors.lastname: Yu
authors.forename: J-M
authors.initials: JM
authors.lastname: Guo
authors.forename: H-T
authors.initials: HT
authors.lastname: Jiang
authors.forename: X-Y
authors.initials: XY
authors.lastname: Di
authors.forename: Y
authors.initials: Y
authors.lastname: Zhu
mesh_terms: D000328:Adult; D000368:Aged; D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000532:radiotherapy*; D015641:Radiography, Interventional / Q000009:adverse effects / Q000379:methods; D025321:Surgery, Computer-Assisted; D014781:Viscera / Q000293:injuries
chemical_list: D007457:Iodine Radioisotopes
references.citation: Br J Cancer. 2007 Apr 23;96(8):1183-90
references.pmid: 17406358
references.citation: Clin Biochem. 2012 Sep;45(13-14):1064-9
references.pmid: 22613268
references.citation: AJR Am J Roentgenol. 2006 Sep;187(3):769-72
references.pmid: 16928943
references.citation: Support Care Cancer. 2000 May;8(3):175-9
references.pmid: 10789956
references.citation: Radiology. 1991 Jan;178(1):253-8
references.pmid: 1984314
references.citation: Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1560-6
references.pmid: 19028278
references.citation: Lung Cancer. 2011 Nov;74(2):253-7
references.pmid: 21513997
references.citation: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references.pmid: 20610543
references.citation: Ann Surg. 2005 Feb;241(2):295-9
references.pmid: 15650640
references.citation: Int J Radiat Oncol Biol Phys. 1992;23(2):305-11
references.pmid: 1587751
references.citation: Ann Surg Oncol. 2009 Jul;16(7):1751-6
references.pmid: 19390900
references.citation: Zhonghua Yi Xue Za Zhi. 2006 Jan 24;86(4):223-7
references.pmid: 16677499
references.citation: Cancer Med. 2013 Oct;2(5):701-11
references.pmid: 24403235
references.citation: Chin Med J (Engl). 2008 Dec 5;121(23):2410-4
references.pmid: 19102958
references.citation: Cancer. 2009 Feb 1;115(3):665-72
references.pmid: 19117351
references.citation: Endoscopy. 2008 Apr;40(4):314-20
references.pmid: 18283622
references.citation: Radiat Oncol. 2011 Oct 18;6:138
references.pmid: 22004599
references.citation: Ann Surg. 1995 Jun;221(6):721-31; discussion 731-3
references.pmid: 7794076
references.citation: Cancer. 2000 Dec 1;89(11):2222-9
references.pmid: 11147592
references.citation: World J Gastroenterol. 2008 Mar 14;14(10):1603-11
references.pmid: 18330956
references.citation: Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1245-51
references.pmid: 16253779
references.citation: Eur Radiol. 2010 Jul;20(7):1786-91
references.pmid: 20069424
references.citation: Radiology. 2002 Jan;222(1):63-9
references.pmid: 11756706
references.citation: J Cell Biochem. 2013 Sep;114(9):2131-7
references.pmid: 23553901
references.citation: Lancet. 2004 Mar 27;363(9414):1049-57
references.pmid: 15051286